These results suggest that the CT26/HER2 tumor-derived in vivo environment, including higher levels of IFN-γ, might not have any inhibitory effect on the induction of Ag-specific CTLs in response to 4T1.2/HER2 cells. The gene discussed is ERBB2; the disease is neoplasm.